SNCA and Parkinson disease: While we can conclude the monomeric α-synuclein is reduced in the hippocampal CA3 region in the MPTP mouse model, the question of whether the hippocampal monomeric α-synuclein also protects memory function in the early phases of PD still remains to be elucidated.